News

Enteris recognized for the third consecutive year in the Pharmaceutical Company category   Boonton, NJ, August 23, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative […]

On June 29 at 1pm ET, Co-Hosts Josh Stephens and Angela Consalvo Will Share Knowledge and Expertise on Selecting CDMOs for HPAPI and SOD Manufacturing   […]

Third milestone payment related to the development of Oral KORSUVA™   Dallas, TX, June 11, 2021  — SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty […]

Enteris to Seek Deeper Development and Manufacturing Opportunities   BOONTON, N.J., June 7, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on […]

CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds   BOONTON, […]

BOONTON, N.J., March 16, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]

Boonton, NJ – January 12, 2021 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned […]